 |
XyloCor Therapeutics
Last updated: May 04, 2024
CEO Albert Gianchetti
Country: USA | Funding: $39.6M (+)
Website: https://xylocor.com/
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Website: https://xylocor.com/
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
